State Street’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.9M Sell
1,595,291
-101,824
-6% -$1.52M ﹤0.01% 2093
2025
Q1
$27.4M Buy
1,697,115
+16,179
+1% +$261K ﹤0.01% 1958
2024
Q4
$39.1M Buy
1,680,936
+139,381
+9% +$3.24M ﹤0.01% 1846
2024
Q3
$45.3M Buy
1,541,555
+131,896
+9% +$3.88M ﹤0.01% 1753
2024
Q2
$33.1M Buy
1,409,659
+1,275,233
+949% +$30M ﹤0.01% 1868
2024
Q1
$5.1M Buy
+134,426
New +$5.1M ﹤0.01% 2916
2023
Q3
Sell
-7,804
Closed -$87.9K 4589
2023
Q2
$87.9K Sell
7,804
-796
-9% -$8.96K ﹤0.01% 4274
2023
Q1
$62.3K Hold
8,600
﹤0.01% 4449
2022
Q4
$96.7K Buy
8,600
+2,240
+35% +$25.2K ﹤0.01% 4376
2022
Q3
$84K Hold
6,360
﹤0.01% 4524
2022
Q2
$80K Sell
6,360
-25,122
-80% -$316K ﹤0.01% 4606
2022
Q1
$1.81M Buy
31,482
+1,160
+4% +$66.7K ﹤0.01% 3605
2021
Q4
$3.6M Sell
30,322
-356
-1% -$42.3K ﹤0.01% 3398
2021
Q3
$6.1M Buy
30,678
+378
+1% +$75.1K ﹤0.01% 3127
2021
Q2
$5.27M Buy
30,300
+1,561
+5% +$272K ﹤0.01% 3223
2021
Q1
$5.69M Sell
28,739
-354
-1% -$70.1K ﹤0.01% 3001
2020
Q4
$5.72M Buy
29,093
+2,819
+11% +$555K ﹤0.01% 2897
2020
Q3
$4.66M Buy
26,274
+162
+0.6% +$28.7K ﹤0.01% 2820
2020
Q2
$6.04M Buy
26,112
+7,244
+38% +$1.68M ﹤0.01% 2663
2020
Q1
$2.2M Buy
18,868
+276
+1% +$32.2K ﹤0.01% 3028
2019
Q4
$3.55M Buy
18,592
+1,324
+8% +$253K ﹤0.01% 3014
2019
Q3
$3.32M Buy
17,268
+1,897
+12% +$365K ﹤0.01% 2996
2019
Q2
$2.63M Buy
15,371
+5,570
+57% +$954K ﹤0.01% 3131
2019
Q1
$1.97M Sell
9,801
-41
-0.4% -$8.25K ﹤0.01% 3153
2018
Q4
$1.84M Sell
9,842
-98
-1% -$18.4K ﹤0.01% 3153
2018
Q3
$2.38M Buy
9,940
+999
+11% +$239K ﹤0.01% 3187
2018
Q2
$2.37M Buy
+8,941
New +$2.37M ﹤0.01% 3185